Savara Inc. (SVRA)
NASDAQ·Healthcare·Biotechnology
$5.01
+2.98%
Mkt Cap $998.54M
Analyst Ratings
No recent rating data.
Price Target (12 analysts)
$10.00
Range $10.00 – $10.00
Implied Upside
+99.6%
Consensus $10.00 vs current $5.01
NASDAQ·Healthcare·Biotechnology
$5.01
+2.98%
Mkt Cap $998.54M
No recent rating data.
Price Target (12 analysts)
$10.00
Range $10.00 – $10.00
+99.6%
Consensus $10.00 vs current $5.01